Who is sponsoring NCT07465237?

NCT07465237 is sponsored by Hacettepe University.

What drugs are being tested in NCT07465237?

Interventions in NCT07465237: Pressure Rise Time Adjustment.

What condition does NCT07465237 study?

NCT07465237 studies Respiratory Distress in Neonates, Mechanical Ventilation.

Is NCT07465237 still recruiting?

NCT07465237 is currently completed. Last updated 11 March 2026.

Last reviewed 2026-03-11 · How we verify

NCT07465237

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pressure Rise Time Modulation During Volume-Guaranteed Neonatal Ventilation

Completed NA Last updated 11 March 2026

What this trial tests

NA trial testing Pressure Rise Time Adjustment in Respiratory Distress in Neonates in 17 participants. Completed in 15 July 2024.

Timeline

15 July 2023

Primary endpoint
15 July 2024

15 July 2024

Quick facts

Lead sponsor	Hacettepe University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	17
Start date	15 July 2023
Primary completion	15 July 2024
Estimated completion	15 July 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Pressure Rise Time Adjustment

Conditions studied

Respiratory Distress in Neonates — all drugs for Respiratory Distress in Neonates →
Mechanical Ventilation — all drugs for Mechanical Ventilation →

Sponsor

Hacettepe University

Who can join

Adults 0 Days to 28 Days, any sex, with Respiratory Distress in Neonates or Mechanical Ventilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the short-term physiological effects of pressure rise time modulation during volume-guaranteed ventilation in neonates. Pressure rise time is an adjustable parameter that influences how quickly inspiratory pressure reaches the target level during mechanical ventilation. In this study, different pressure rise time settings will be applied during volume-guaranteed ventilation, and their effects on respiratory parameters, gas exchange, and patient-ventilator interaction will be evaluated. The aim is to determine whether modulation of pressure rise time has measurable short-term physiological effects in ventilated neonates and to identify optimal ventilator settings that may improve respiratory support.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Short-term physiological effects of pressure rise time modulation during volume-guaranteed neonatal ventilation.
Aliyev F, Yigit S, Yucel E, Tandircioğlu UA. · · 2026 · PMID 41912661 · DOI 10.1038/s41598-026-44486-5

Verify or expand the search:

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07465237 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 11 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07465237.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing